LFST RSI Chart
Last 7 days
7.7%
Last 30 days
29.9%
Last 90 days
11.6%
Trailing 12 Months
-10.2%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 1.1B | 0 | 0 | 0 |
2023 | 909.0M | 959.1M | 1.0B | 1.1B |
2022 | 727.5M | 776.5M | 820.2M | 859.5M |
2021 | 408.7M | 523.8M | 595.6M | 667.5M |
2020 | 0 | 253.7M | 336.0M | 377.2M |
2019 | 0 | 0 | 0 | 212.5M |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 01, 2024 | mullins kevin michael | sold | -57,449 | 5.93 | -9,688 | chief development officer |
Apr 01, 2024 | pantaleoni pablo | sold | -59,987 | 5.93 | -10,116 | chief digital officer |
Apr 01, 2024 | qureshi danish j. | sold | -76,882 | 5.93 | -12,965 | see remarks |
Apr 01, 2024 | pardo ryan | sold | -58,291 | 5.93 | -9,830 | see remarks |
Mar 15, 2024 | burdick kenneth a | sold | -1,347,720 | 6.28 | -214,605 | chief executive officer |
Mar 14, 2024 | pardo ryan | sold | -249,301 | 6.33 | -39,384 | see remarks |
Mar 14, 2024 | mullins kevin michael | sold | -281,938 | 6.33 | -44,540 | chief development officer |
Mar 13, 2024 | qureshi danish j. | sold | -972,920 | 6.32 | -153,943 | see remarks |
Mar 12, 2024 | pantaleoni pablo | sold | -292,735 | 6.76 | -43,304 | chief digital officer |
Mar 11, 2024 | cipollone paula | sold | -96,992 | 6.93 | -13,996 | see remarks |
Which funds bought or sold LFST recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | added | 13.01 | -72,656 | 590,827 | -% |
May 16, 2024 | JANE STREET GROUP, LLC | added | 106 | 248,873 | 643,747 | -% |
May 16, 2024 | COMERICA BANK | reduced | -88.16 | -11,395 | 1,172 | -% |
May 15, 2024 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | new | - | 1,891,230 | 1,891,230 | 0.01% |
May 15, 2024 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | sold off | -100 | -2,905 | - | -% |
May 15, 2024 | TWO SIGMA INVESTMENTS, LP | added | 124 | 425,193 | 975,415 | -% |
May 15, 2024 | OCCUDO QUANTITATIVE STRATEGIES LP | reduced | -82.02 | -512,601 | 84,609 | 0.01% |
May 15, 2024 | Tower Research Capital LLC (TRC) | reduced | -92.55 | -176,599 | 11,008 | -% |
May 15, 2024 | Cubist Systematic Strategies, LLC | new | - | 420,244 | 420,244 | -% |
May 15, 2024 | MARSHALL WACE, LLP | new | - | 754,240 | 754,240 | -% |
Unveiling LifeStance Health Group, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to LifeStance Health Group, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 482.9B | 379.5B | 31.44 | 1.27 | ||||
CI | 96.2B | 206.0B | 24.97 | 0.47 | ||||
HCA | 84.6B | 66.7B | 15.46 | 1.27 | ||||
CVS | 72.4B | 360.9B | 9.89 | 0.2 | ||||
CNC | 41.7B | 155.5B | 15.24 | 0.27 | ||||
DVA | 12.3B | 12.3B | 15.03 | 0.99 | ||||
UHS | 11.9B | 14.7B | 14.63 | 0.81 | ||||
MID-CAP | ||||||||
CHE | 8.5B | 2.3B | 30.15 | 3.73 | ||||
ACHC | 6.2B | 3.0B | -545.12 | 2.06 | ||||
AMEH | 2.3B | 1.5B | 36.62 | 1.57 | ||||
AMN | 2.2B | 3.5B | 15.49 | 0.64 | ||||
SMALL-CAP | ||||||||
ADUS | 1.8B | 1.1B | 27.59 | 1.67 | ||||
BKD | 1.3B | 3.0B | -7.66 | 0.44 | ||||
BEAT | 54.5M | - | -3.61 | - | ||||
AMS | 22.0M | 21.6M | 39.79 | 1.02 |
LifeStance Health Group, Inc. News
Income Statement (Quarterly) | |||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q2 | 2019Q4 |
Revenue | 7.1% | 300,437,000 | 280,603,000 | 262,895,000 | 259,578,000 | 252,589,000 | 229,360,000 | 217,560,000 | 209,527,000 | 203,095,000 | 189,995,000 | 173,835,000 | 160,549,000 | 143,132,000 | 118,121,000 | 101,982,000 | 45,453,000 | 111,661,000 | - |
Operating Expenses | 1.4% | 317,209,000 | 312,874,000 | 337,252,000 | 307,991,000 | 286,682,000 | 275,372,000 | 256,399,000 | 269,999,000 | 267,946,000 | 303,754,000 | 298,503,000 | 207,594,000 | 144,013,000 | 114,175,000 | 99,291,000 | 45,349,000 | 102,966,000 | - |
S&GA Expenses | -4.7% | 88,934,000 | 93,368,000 | 130,945,000 | 101,854,000 | 84,626,000 | 89,817,000 | 81,248,000 | 103,559,000 | 103,369,000 | 152,652,000 | 162,943,000 | 85,479,000 | 32,651,000 | 23,665,000 | 19,534,000 | 8,642,000 | 20,854,000 | - |
EBITDA Margin | 24.3% | -0.08 | -0.10 | -0.12 | -0.10 | -0.12 | -0.17 | -0.26 | -0.39 | -0.41 | -0.36 | -0.22 | -0.01 | - | - | - | - | - | - |
Interest Expenses | 6.7% | 5,903,000 | 5,532,000 | 5,477,000 | 5,119,000 | 5,092,000 | 5,165,000 | 4,189,000 | 7,133,000 | 3,441,000 | 3,602,000 | 3,503,000 | 23,174,000 | 8,632,000 | 7,129,000 | 6,421,000 | 5,562,000 | 3,020,000 | - |
Income Taxes | -94.5% | 363,000 | 6,643,000 | -16,385,000 | -6,542,000 | -4,037,000 | -7,060,000 | -4,353,000 | 923,000 | -6,676,000 | -10,608,000 | -8,751,000 | -3,788,000 | -2,761,000 | -2,948,000 | -1,074,000 | 1,370,000 | -2,319,000 | - |
Earnings Before Taxes | 45.9% | -20,734,000 | -38,316,000 | -77,968,000 | -52,020,000 | -38,279,000 | -53,716,000 | -42,206,000 | -67,804,000 | -69,004,000 | -118,638,000 | -129,203,000 | -73,821,000 | -11,443,000 | -7,067,000 | -4,368,000 | -5,712,000 | -27,264,000 | - |
EBT Margin | 12.5% | -0.17 | -0.20 | -0.22 | -0.19 | -0.22 | -0.27 | -0.36 | -0.50 | -0.54 | -0.50 | -0.37 | -0.18 | - | - | - | - | - | - |
Net Income | 53.1% | -21,097,000 | -44,959,000 | -61,583,000 | -45,478,000 | -34,242,000 | -46,656,000 | -37,853,000 | -68,727,000 | -62,328,000 | -108,030,000 | -120,452,000 | -70,033,000 | -8,682,000 | -5,489,000 | -3,294,000 | -4,342,000 | -24,945,000 | - |
Net Income Margin | 11.1% | -0.16 | -0.18 | -0.19 | -0.17 | -0.21 | -0.25 | -0.34 | -0.46 | -0.50 | -0.46 | -0.34 | -0.17 | - | - | - | - | - | - |
Free Cashflow | -600.7% | -26,942,000 | 5,381,000 | -35,151,000 | -12,015,000 | -15,619,000 | 25,534,000 | -9,366,000 | -18,032,000 | -24,602,000 | -8,042,000 | -38,221,000 | -37,637,000 | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2020Q4 |
Assets | -0.2% | 2,106 | 2,110 | 2,175 | 2,171 | 2,159 | 2,174 | 1,980 | 1,969 | 1,958 | 1,927 | 1,915 | 1,914 | 1,570 |
Current Assets | 8.1% | 244 | 226 | 264 | 238 | 213 | 233 | 253 | 244 | 263 | 267 | 328 | 364 | 76.00 |
Cash Equivalents | -37.3% | 49.00 | 79.00 | 43.00 | 80.00 | 68.00 | 109 | 90.00 | 97.00 | 114 | 148 | 212 | 276 | 19.00 |
Net PPE | -3.1% | 182 | 188 | 190 | 193 | 194 | 194 | 193 | 191 | 171 | 152 | 115 | 92.00 | 59.00 |
Goodwill | 0% | 1,293 | 1,293 | 1,293 | 1,294 | 1,294 | 1,273 | 1,250 | 1,244 | 1,229 | 1,205 | 1,160 | 1,139 | 1,099 |
Liabilities | -0.5% | 677 | 681 | 720 | 676 | 653 | 655 | 448 | 437 | 416 | 382 | 370 | 370 | 537 |
Current Liabilities | 2.3% | 207 | 203 | 241 | 181 | 181 | 176 | 112 | 112 | 126 | 117 | 105 | 113 | 76.00 |
Long Term Debt | -0.1% | 280 | 280 | 248 | 249 | 225 | 225 | 212 | 203 | 177 | 157 | 157 | 157 | 363 |
LT Debt, Non Current | -100.0% | - | 280 | 248 | 249 | 225 | 225 | 212 | 203 | 177 | 157 | 157 | 157 | 363 |
Shareholder's Equity | 0.0% | 1,429 | 1,429 | 1,455 | 1,495 | 1,505 | 1,519 | 1,532 | 1,531 | 1,543 | 1,545 | 1,545 | 1,545 | 998 |
Retained Earnings | -2.8% | -781 | -760 | -715 | -654 | -608 | -572 | -525 | -488 | -419 | -357 | -249 | -128 | -13.12 |
Additional Paid-In Capital | 0.9% | 2,204 | 2,184 | 2,163 | 2,141 | 2,108 | 2,084 | 2,051 | 2,016 | 1,958 | 1,898 | 1,790 | 1,669 | 1.00 |
Shares Outstanding | 0.9% | 382 | 379 | 379 | 378 | 377 | 376 | 376 | 376 | 374 | 374 | 374 | 374 | - |
Float | - | - | - | - | 965 | - | - | - | 405 | - | - | - | 1,996 | - |
Cashflow (Quarterly) | |||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q2 | 2019Q4 |
Cashflow From Operations | -230.0% | -21,838 | 16,795 | -25,355 | -434 | -7,890 | 35,918 | 5,730 | 7,833 | 3,308 | 30,635 | -14,209 | -16,915 | 9,909 | 4,160 | 11,188 | -37,317 | 13,436 | - |
Share Based Compensation | -1.6% | 20,581 | 20,919 | 21,525 | 33,078 | 23,866 | 35,195 | 34,870 | 57,510 | 59,855 | 108,630 | 120,689 | 29,515 | 605 | 587 | 573 | 292 | - | - |
Cashflow From Investing | 55.3% | -5,104 | -11,414 | -9,796 | -11,581 | -27,549 | -30,296 | -20,272 | -38,038 | -50,855 | -79,562 | -43,585 | -59,094 | -11,835 | -144,644 | -20,234 | -671,213 | -25,078 | - |
Cashflow From Financing | -107.9% | -2,431 | 30,838 | -1,849 | 23,326 | -4,888 | 12,663 | 8,192 | 12,901 | 13,508 | -15,167 | -6,270 | 312,702 | 22,591 | 134,245 | 20,310 | 722,334 | 35,385 | - |
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
TOTAL REVENUE | $ 300,437 | $ 252,589 |
OPERATING EXPENSES | ||
Center costs, excluding depreciation and amortization shown separately below | 205,711 | 182,987 |
General and administrative expenses | 88,934 | 84,626 |
Depreciation and amortization | 22,564 | 19,069 |
Total operating expenses | 317,209 | 286,682 |
LOSS FROM OPERATIONS | (16,772) | (34,093) |
OTHER EXPENSE | ||
Gain on remeasurement of contingent consideration | 2,015 | 1,037 |
Transaction costs | 0 | (86) |
Interest expense, net | (5,903) | (5,092) |
Other expense | (74) | (45) |
Total other expense | (3,962) | (4,186) |
LOSS BEFORE INCOME TAXES | (20,734) | (38,279) |
INCOME TAX (PROVISION) BENEFIT | (363) | 4,037 |
NET LOSS | $ (21,097) | $ (34,242) |
NET LOSS PER SHARE, BASIC | $ (0.06) | $ (0.09) |
NET LOSS PER SHARE, DILUTED | $ (0.06) | $ (0.09) |
Weighted-average shares used to compute basic net loss per share | 376,331 | 360,902 |
Weighted-average shares used to compute diluted net loss per share | 376,331 | 360,902 |
Net Income (Loss) | $ (21,097) | $ (34,242) |
OTHER COMPREHENSIVE (LOSS) | ||
Unrealized gains (losses) on cash flow hedge, net of tax | 583 | (1,270) |
COMPREHENSIVE LOSS | $ (20,514) | $ (35,512) |
CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
CURRENT ASSETS | ||
Cash and cash equivalents | $ 49,451 | $ 78,824 |
Patient accounts receivable, net | 175,937 | 125,405 |
Prepaid expenses and other current assets | 18,729 | 21,502 |
Total current assets | 244,117 | 225,731 |
NONCURRENT ASSETS | ||
Property and equipment, net | 182,428 | 188,222 |
Right-of-use assets | 165,845 | 170,703 |
Intangible assets, net | 208,529 | 221,072 |
Goodwill | 1,293,346 | 1,293,346 |
Other noncurrent assets | 12,051 | 10,895 |
Total noncurrent assets | 1,862,199 | 1,884,238 |
Total assets | 2,106,316 | 2,109,969 |
CURRENT LIABILITIES | ||
Accounts payable | 11,938 | 7,051 |
Accrued payroll expenses | 100,432 | 102,478 |
Other accrued expenses | 37,272 | 35,012 |
Contingent consideration | 4,454 | 8,169 |
Operating lease liabilities, current | 49,729 | 46,475 |
Other current liabilities | 3,639 | 3,688 |
Total current liabilities | 207,464 | 202,873 |
NONCURRENT LIABILITIES | ||
Long-term debt, net | 279,870 | 280,285 |
Operating lease liabilities, noncurrent | 173,255 | 181,357 |
Deferred tax liability, net | 15,970 | 15,572 |
Other noncurrent liabilities | 760 | 952 |
Total noncurrent liabilities | 469,855 | 478,166 |
Total liabilities | 677,319 | 681,039 |
COMMITMENTS AND CONTINGENCIES (see Note 12) | ||
STOCKHOLDERS' EQUITY | ||
Preferred stock - par value $0.01 per share; 25,000 shares authorized as of March 31,2024 and December 31, 2023; 0 shares issued and outstanding as of March 31, 2024 and December 31,2023 | 0 | 0 |
Common stock - par value $0.01 per share 800,000 shares authorized as of March 31,2024 and December 31, 2023 ; 378,725 and 378,725 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | 3,821 | 3,789 |
Additional paid-in capital | 2,204,233 | 2,183,684 |
Accumulated other comprehensive income | 2,886 | 2,303 |
Accumulated deficit | (781,943) | (760,846) |
Total stockholders' equity | 1,428,997 | 1,428,930 |
Total liabilities and stockholders' equity | $ 2,106,316 | $ 2,109,969 |